Skip to content

CapEx at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$2.08M-95.2%
United Therapeutics logo
United TherapeuticsUTHR
$100.8M+34.6%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$165K+31.0%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$6.07M+146%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$230.6M+0.6%
Savara logo
SavaraSVRA
$54K+1,700%

Other financials

Income statement

See full
Revenue$306.0M+230%
Gross profit$258.5M+261%
Operating income-$153.3M+38.2%
Net income-$163.6M+36.3%
EPS (diluted)-$0.76+46.5%

Balance sheet

See full
Cash & equivalents$582.2M+44.4%
Total debt$580.3M-49.2%
Total equity$704.9M+611%
Total assets$2.1B+15.2%

Cash flow

See full
Operating cash flow-$222.7M+15.0%
Free cash flow-$226.2M+16.9%

Valuation

See full
Market cap$23.11B+25.2%
Enterprise value$23.11B+29.9%
P/S28.2×-18.2×

Profitability

See full
Gross margin81.8%+5.3pp
Operating margin-140.6%-43.9pp
Net margin-144.4%-45.3pp
FCF margin-112.5%-35.3pp

Returns & leverage

See full
Return on equity-294.5%
Debt / equity0.8×-10.7×
Current ratio4.5×-1.4×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insmed's capex?
Insmed (INSM) reported capex of $3.48M in Q1 2026.
How has Insmed's capex changed year-over-year?
Insmed's capex decreased by 65.4% year-over-year, from $10.07M to $3.48M.
What is the long-term trend for Insmed's capex?
Over 4 years (2021 to 2025), Insmed's capex has grown at a 45.4% compound annual growth rate (CAGR), from $7.29M to $32.56M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.